Skip to main content
Mandjes IAM on Muck Rack

Mandjes IAM

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mandjes

Contact Mandjes, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial

|
By Haanen JBAG, Geurts VCM, van Dongen MGJ, Mandjes IAM
| ncbi.nlm.nih.gov
doi: 10.1016/j.breast.2023.06.007. Online ahead of print. Affiliations Affiliations 1 Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: V.Geurts@nki.nl. 2 Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: L.Voorwerk@nki.nl. 3 Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: S.Balduzzi@nki.nl.
Open in Who Shared Issue with article?
See all 1 articles